FileWave เวอร์ชั่น 12.8 รองรับระบบปฏิบัติการ iOS 11.3, tvOS 11.3 และ macOS 10.13.4 อย่างเต็มรูปแบบ
FileWave ผู้นำระดับโลกด้านการจัดการอุปกรณ์มัลติแพลตฟอร์ม ประกาศปล่อยเวอร์ชั่น 12.8 ที่รองรับระบบปฏิบัติการล่าสุดของ Apple อย่างเต็มรูปแบบ อันที่จริง FileWave รองรับระบบ iOS 11.3, tvOS 11.3 และ macOS 10.13.4 อยู่แล้ว แต่เวอร์ชั่น 12.8 จะช่วยเพิ่มความสามารถในการรองรับฟีเจอร์ใหม่ๆ ที่มาพร้อมกับการอัปเดตของ Apple
ฟีเจอร์เด่นของ FileWave เวอร์ชั่น 12.8 ประกอบด้วย
- ผู้ดูแลระบบสามารถเลือกเวลาและเวอร์ชั่นในการอัปเดตระบบปฏิบัติการ
- ตัวเลือก DEP ใหม่ๆ ที่เหมาะกับผู้ใช้แต่ละคน
- รูปแบบคำสั่ง MDM ที่มีมากขึ้น
- เปลี่ยนโปรไฟล์ได้หลายแบบ เช่น Autonomous Single App Mode และ Content Caching
ฟีเจอร์ใหม่ในเวอร์ชั่น 12.8 จะช่วยให้ผู้ดูแลระบบไอทีสามารถจัดการกับอุปกรณ์ Apple ได้ดีขึ้น โดยใช้โซลูชั่นและอินเตอร์เฟสเดียวกับที่ใช้จัดการอุปกรณ์ Windows และ Chrome ทั้งนี้ สามารถดูวิดีโอสรุปภาพรวมและรายละเอียดของฟีเจอร์ใหม่ได้ที่ https://www.filewave.com/the-news/filewave-12-8
ทิม วิลเลียมส์ รองประธานฝ่ายการตลาดสากลและกลยุทธ์ผลิตภัณฑ์ของ FileWave กล่าวว่า "เรารู้สึกดีที่ได้ยกระดับการจัดการอุปกรณ์ Apple ด้วยฟีเจอร์ใหม่ๆ เรารองรับเทคโนโลยีของ Apple มานานถึง 25 ปีแล้ว ซึ่งแทบไม่มีโซลูชั่นมัลติแพลตฟอร์มอื่นใดทำได้ และหลังจากที่ LANrev ประกาศยุติการให้บริการ เราก็แทบจะเป็นโซลูชั่นมัลติแพลตฟอร์มหนึ่งเดียวในตลาด"
คุณวิลเลียมส์ ซึ่งมีประสบการณ์นานกว่า 7 ปีในการทำงานกับ LANrev กล่าวว่า "หลายคนที่เคยทำงานกับ LANrev ต่างย้ายมาร่วมงานกับ FileWave และรอคอยที่จะกลับมาติดต่อกับลูกค้าอีกครั้ง"
เกี่ยวกับ FILEWAVE
FileWave ก่อตั้งขึ้นในปี 2535 และเป็นผู้บุกเบิกการจัดการอุปกรณ์มัลติแพลตฟอร์ม บริษัทนำเสนอโซลูชั่นครบวงจรในการจัดการแอป อุปกรณ์ และคอนฟิกเกอเรชั่นของ Mac, Windows และอุปกรณ์เคลื่อนที่ FileWave ช่วยให้ฝ่ายไอทีสามารถควบคุมดูแลอุปกรณ์ในเชิงรุกและเป็นอัตโนมัติ อีกทั้งยังช่วยให้การจัดการอุปกรณ์มัลติแพลตฟอร์มเป็นเรื่องง่าย
รับชมข้อมูลเพิ่มเติมเกี่ยวกับ FileWave หรือทดลองใช้งานได้ที่ https://www.filewave.com
ข้อมูลติดต่อ
Jason Noel
FileWave
โทร. (888) 345-3928
อีเมล: pr@filewave.com
Friday, April 27, 2018
FileWave extends robust support for Apple technologies in a multi-platform solution, with version 12.8
Endpoint management provider, FileWave, announces release of version 12.8 with full support for iOS 11.3, tvOS 11.3, and macOS 10.13.4
FileWave, a global leader in multi-platform endpoint management, announced today its release of FileWave 12.8, featuring full support for Apple's latest operating systems. Although FileWave was compatible with iOS 11.3, tvOS 11.3, and macOS 10.13.4 upon their release, version 12.8 adds support for the new features introduced in these Apple updates.
Notable features of FileWave 12.8 include:
- Administrator controlled timing and versioning of OS updates
- New DEP profile options for a customized user experience
- Expanded MDM commands
- Various profile changes, including Autonomous Single App Mode and Content Caching
The new features found in version 12.8 enable IT administrators to better manage their Apple devices using the same management solution and interface that is used to manage their Windows and Chrome devices. A complete breakdown of the new features, including a video overview, is available at https://www.filewave.com/the-news/filewave-12-8 .
"We're excited to follow up on our zero-day support for the Apple spring release with added support for all of the new features," said Tim Williams, VP Global Marketing and Product Strategy at FileWave. "We have a 25-year tradition of the most robust support for Apple technologies, which is rare in a multi-platform solution. With the recent end-of-life announcement for LANrev, we are just about the only multi-platform option on the market."
Williams, who spent more than seven years with LANrev, added that "the many former LANrev team members who've joined FileWave look forward to reconnecting with our customers."
ABOUT FILEWAVE
A pioneer in Multi-platform Endpoint Management, FileWave was founded in 1992. Offering a single management solution for apps, devices, and configurations for Mac, Windows, and mobile, FileWave gives IT the ability to proactively and automatically provision and maintain every device. FileWave makes multi-platform endpoint management simple.
To learn more about FileWave, or to begin a free trial, visit https://www.filewave.com .
Contact Information
Jason Noel
FileWave
(888) 345-3928
pr@filewave.com
FileWave, a global leader in multi-platform endpoint management, announced today its release of FileWave 12.8, featuring full support for Apple's latest operating systems. Although FileWave was compatible with iOS 11.3, tvOS 11.3, and macOS 10.13.4 upon their release, version 12.8 adds support for the new features introduced in these Apple updates.
Notable features of FileWave 12.8 include:
- Administrator controlled timing and versioning of OS updates
- New DEP profile options for a customized user experience
- Expanded MDM commands
- Various profile changes, including Autonomous Single App Mode and Content Caching
The new features found in version 12.8 enable IT administrators to better manage their Apple devices using the same management solution and interface that is used to manage their Windows and Chrome devices. A complete breakdown of the new features, including a video overview, is available at https://www.filewave.com/the-news/filewave-12-8 .
"We're excited to follow up on our zero-day support for the Apple spring release with added support for all of the new features," said Tim Williams, VP Global Marketing and Product Strategy at FileWave. "We have a 25-year tradition of the most robust support for Apple technologies, which is rare in a multi-platform solution. With the recent end-of-life announcement for LANrev, we are just about the only multi-platform option on the market."
Williams, who spent more than seven years with LANrev, added that "the many former LANrev team members who've joined FileWave look forward to reconnecting with our customers."
ABOUT FILEWAVE
A pioneer in Multi-platform Endpoint Management, FileWave was founded in 1992. Offering a single management solution for apps, devices, and configurations for Mac, Windows, and mobile, FileWave gives IT the ability to proactively and automatically provision and maintain every device. FileWave makes multi-platform endpoint management simple.
To learn more about FileWave, or to begin a free trial, visit https://www.filewave.com .
Contact Information
Jason Noel
FileWave
(888) 345-3928
pr@filewave.com
Air China Limited Announces 2018 First Quarter Results: Improving Development Quality to Achieve Significant Growth in Profit
BEIJING--27 Apr--PRNewswire/InfoQuest
Air China Limited ("Air China" or the "Company," together with its subsidiaries, collectively the " Group") (HKEX: 00753; LSE: AIRC; SSE: 601111; ADR OTC: AIRYY), today announced its first quarter results of 2018 (the "Period").
Results Highlights
- Total profit increased 66.31% year-on-year to RMB4.024 billion
- Operating income increased 9.11% year-on-year to RMB31.607 billion
- Total operating cost increased 6.71% year-on-year to RMB 28.230 billion
Operation and Business Highlights
In the first quarter of 2018, the Chinese economy developed steadily. As residents' demand for travel was strong, air passenger traffic maintained steady growth while demand in the cargo market continued to improve. During the Period, the Group recorded operating income of RMB31.607 billion, an increase of 9.11% over the same period of last year. Total operating cost was RMB 28.230 billion, an increase of 6.71% over the same period of last year. Total profit was RMB4.024 billion, an increase of 66.31% over the same period of last year, and net profit attributable to shareholders of listed companies was RMB2.628 billion, an increase of 79.23% over the same period of last year.
During the Period, the Group's passenger capacity, measured by Available Seat Kilometers (ASK) increased by 10.96% year on year to 65.758 billion. The passenger traffic, measured by Revenue Passenger Kilometers (RPK) was 53.350 billion, an increase of 9.75% year on year. Among which, RPK of domestic routes, international routes and regional routes amounted to 32.596 billion, 18.849 billion, and 1.905 billion, up 7.44%,13.65% and 12.92% year on year, respectively. The passenger load factor was 81.13%, a slight decrease of 0.90 percentage points year on year, of which, the passenger load factor of domestic, international and regional routes were 83.02%, 78.28% and 78.90% respectively.
In terms of air cargo, the Available Freight Tonne Kilometers (AFTK) amounted to 3.518 billion, up 9.81% year on year, while the Revenue Freight Tonne Kilometers (RFTK) amounted to 1.803 billion, up 10.90% year on year. The cargo and mail load factor was 51.26%, up 0.51 percentage points year on year.
Outlook
Benefitting from the continued development of the global aviation industry, steady growth of China's macro economy, and the influence of a series of policies favourable to the industry, we expect the Company will have larger room for development this year. Adhering to the development philosophy of "Innovation, Coordination, Green, Openness and Sharing", the Group will persist in making progress while pursuing stability, continue to deepen reform and innovation, strengthen cost management and control, optimize capital and debt structure, and consolidate and enhance competitive advantages, so as to achieve better performance and sustainable development to its utmost ability.
About Air China
Air China Limited (Air China) is the national flag carrier of China and a leading provider of passenger, air cargo and airline-related services and products in China. Its operational headquarters is in Beijing, a major domestic and international hub in China. It also provides airline-related services, including aircraft maintenance, ground handling services in Beijing, Chengdu, and other locations. As of 31 December, 2017, the Group operated a fleet of 655 aircraft with an average age of 6.53 years, while the Company operated a fleet of 396 aircraft with an average age of 6.57 years. Passenger traffic routes have reached 420, including 101 international, 16 regional and 303 domestic routes. The Company's network covered 40 countries and regions globally and 185 cities, including 66 international, 3 regional and 116 domestic cities. Air China was listed on Hong Kong Stock Exchange and London Stock Exchange on 15 December, 2004 under codes 00753 and AIRC respectively. On June 30, 2006, a level 1 sponsored ADR program was set up for Air China with the ticker AIRYY. On August 18, 2006, Air China was listed on Shanghai Stock Exchange under code 601111. For further details, please visit Air China's website: www.airchina.com.cn .
Safe Harbor Statement
This press release contains projections and forward-looking statements that reflect the company's current views with respect to future events and financial performance. These views are based on current assumptions which are subject to various risks and which may change over time. No assurance can be given that future events will occur that projections will be achieved, or that the company's assumptions are correct. Actual results may differ materially from those projections.
Logo - https://photos.prnasia.com/prnh/20180323/2086726-1LOGO
Air China Limited ("Air China" or the "Company," together with its subsidiaries, collectively the " Group") (HKEX: 00753; LSE: AIRC; SSE: 601111; ADR OTC: AIRYY), today announced its first quarter results of 2018 (the "Period").
Results Highlights
- Total profit increased 66.31% year-on-year to RMB4.024 billion
- Operating income increased 9.11% year-on-year to RMB31.607 billion
- Total operating cost increased 6.71% year-on-year to RMB 28.230 billion
Operation and Business Highlights
In the first quarter of 2018, the Chinese economy developed steadily. As residents' demand for travel was strong, air passenger traffic maintained steady growth while demand in the cargo market continued to improve. During the Period, the Group recorded operating income of RMB31.607 billion, an increase of 9.11% over the same period of last year. Total operating cost was RMB 28.230 billion, an increase of 6.71% over the same period of last year. Total profit was RMB4.024 billion, an increase of 66.31% over the same period of last year, and net profit attributable to shareholders of listed companies was RMB2.628 billion, an increase of 79.23% over the same period of last year.
During the Period, the Group's passenger capacity, measured by Available Seat Kilometers (ASK) increased by 10.96% year on year to 65.758 billion. The passenger traffic, measured by Revenue Passenger Kilometers (RPK) was 53.350 billion, an increase of 9.75% year on year. Among which, RPK of domestic routes, international routes and regional routes amounted to 32.596 billion, 18.849 billion, and 1.905 billion, up 7.44%,13.65% and 12.92% year on year, respectively. The passenger load factor was 81.13%, a slight decrease of 0.90 percentage points year on year, of which, the passenger load factor of domestic, international and regional routes were 83.02%, 78.28% and 78.90% respectively.
In terms of air cargo, the Available Freight Tonne Kilometers (AFTK) amounted to 3.518 billion, up 9.81% year on year, while the Revenue Freight Tonne Kilometers (RFTK) amounted to 1.803 billion, up 10.90% year on year. The cargo and mail load factor was 51.26%, up 0.51 percentage points year on year.
Outlook
Benefitting from the continued development of the global aviation industry, steady growth of China's macro economy, and the influence of a series of policies favourable to the industry, we expect the Company will have larger room for development this year. Adhering to the development philosophy of "Innovation, Coordination, Green, Openness and Sharing", the Group will persist in making progress while pursuing stability, continue to deepen reform and innovation, strengthen cost management and control, optimize capital and debt structure, and consolidate and enhance competitive advantages, so as to achieve better performance and sustainable development to its utmost ability.
About Air China
Air China Limited (Air China) is the national flag carrier of China and a leading provider of passenger, air cargo and airline-related services and products in China. Its operational headquarters is in Beijing, a major domestic and international hub in China. It also provides airline-related services, including aircraft maintenance, ground handling services in Beijing, Chengdu, and other locations. As of 31 December, 2017, the Group operated a fleet of 655 aircraft with an average age of 6.53 years, while the Company operated a fleet of 396 aircraft with an average age of 6.57 years. Passenger traffic routes have reached 420, including 101 international, 16 regional and 303 domestic routes. The Company's network covered 40 countries and regions globally and 185 cities, including 66 international, 3 regional and 116 domestic cities. Air China was listed on Hong Kong Stock Exchange and London Stock Exchange on 15 December, 2004 under codes 00753 and AIRC respectively. On June 30, 2006, a level 1 sponsored ADR program was set up for Air China with the ticker AIRYY. On August 18, 2006, Air China was listed on Shanghai Stock Exchange under code 601111. For further details, please visit Air China's website: www.airchina.com.cn .
Safe Harbor Statement
This press release contains projections and forward-looking statements that reflect the company's current views with respect to future events and financial performance. These views are based on current assumptions which are subject to various risks and which may change over time. No assurance can be given that future events will occur that projections will be achieved, or that the company's assumptions are correct. Actual results may differ materially from those projections.
Logo - https://photos.prnasia.com/prnh/20180323/2086726-1LOGO
Werfen เผยยอดขายเพิ่มกว่า 13% ตอกย้ำความเป็นผู้นำโลกด้านผลิตภัณฑ์ชุดตรวจวินิจฉัย
บาร์เซโลนา, สเปน--27 เม.ย.--พีอาร์นิวส์ไวร์/อินโฟเควสท์
Werfen ผู้นำระดับโลกด้านการดูแลสุขภาพและชีววิทยาศาสตร์ ทำรายได้ถึง 1,337 ล้านยูโรในปี 2560 เพิ่มขึ้น 13.3% จากปี 2559
หากไม่รวมรายการที่เกิดจากการซื้อกิจการ ยอดขายจากธุรกิจเดิม (organic growth) ของบริษัทเติบโตขึ้น 4.6% ซึ่งผลประกอบการดังกล่าวนี้ทำให้ Werfen ยังคงเป็นผู้นำโลกด้านผลิตภัณฑ์ชุดตรวจวินิจฉัย (In Vitro Diagnostics) โดยบริษัทเป็นผู้จัดหาโซลูชั่นระดับนวัตกรรมให้กับโรงพยาบาลและธุรกิจห้องปฏิบัติการทางการแพทย์ ที่มีจุดมุ่งหมายเพื่อยกระดับการดูแลผู้ป่วย และลดค่าใช้จ่ายด้านการดูแลสุขภาพ
Werfen รายงานผลกำไรสุทธิ 160 ล้านยูโรในปี 2560 เพิ่มขึ้น 15.1% จากปี 2559 ขณะที่EBITDA เพิ่มขึ้น 6% แตะ 284 ล้านยูโร
Werfen มีผลการดำเนินดีมากในสาขาหลักที่บริษัทเชี่ยวชาญ เช่น Hemostasis (การห้ามเลือด) โตขึ้น 7.5% ขณะที่ Autoimmunity (ภูมิแพ้ตนเอง) ขยายตัว 6.6% ในขณะที่ไลน์ธุรกิจใหม่อย่าง Acute Care Diagnostics (การตรวจวินิจฉัยโรคเฉียบพลัน) มีอัตราการเติบโตที่ 4.8%
การขยายกลุ่มผลิตภัณฑ์เป็นหนึ่งในปัจจัยหลักที่ทำให้ยอดขายปรับตัวสูงขึ้น หลังจากที่บริษัทได้เข้าซื้อกิจการของ Tem and Accriva Diagnostics และส่งผลให้ไลน์ธุรกิจ Critical Care ได้พัฒนาไปเป็น Acute Care Diagnostics ซึ่งนำเสนอโซลูชั่นที่ครอบคลุมการดูแลในภาวะฉุกเฉิน การบาดเจ็บ และห้องผ่าตัด
Werfen ได้เสริมแกร่งธุรกิจในทุกภูมิภาคของโลก โดยเฉพาะอย่างยิ่งในจีน ที่ยอดขายพุ่งขึ้น 21% เมื่อเทียบกับปี 2559 โดยปัจจุบัน ยอดขายในภูมิภาคเอเชียแปซิฟิกคิดเป็นสัดส่วน 16% ของรายได้รวมของบริษัท
ยุโรปตะวันตกถือเป็นตลาดที่แข็งแกร่งที่สุด คิดเป็น 42% ของรายได้ทั้งหมดของ Werfen ขณะที่อเมริกาเหนือมีสัดส่วนอยู่ที่ 26% ส่วนภูมิภาคที่มีโอกาสเติบโตมากที่สุดได้แก่ ละตินอเมริกา และภูมิภาค EEMEAI (ยุโรปตะวันออก ตะวันออกกลาง แอฟริกา และอินเดีย) ซึ่งต่างทำยอดขายคิดเป็น 8% ของรายได้ทั้งหมด
สำหรับเป้าหมายที่ตั้งไว้สำหรับปี 2561 นี้ คือการสร้างความแข็งแกร่งในสาขาหลักที่บริษัทมีความเชี่ยวชาญ เดินหน้าธุรกิจในจีนให้เติบโตขึ้น และผลักดันการขยายธุรกิจในตลาดเกิดใหม่ เช่น ละตินอเมิรกา เอเชียแปซิฟิก และ EEMEAI
WERFEN เป็นหนึ่งในบริษัทชั้นนำระดับโลกด้าน IVD และดำเนินธุรกิจผ่านบริษัทในเครือ ได้แก่ Instrumentation Laboratory (Hemostasis, Acute Care Diagnostics), Inova Diagnostics (Autoimmunity) และ Biokit (OEM, การตรวจทางปฏิกริยาน้ำเหลืองเพื่อรักษาโรคติดเชื้อ) โดยนอกเหนือจากซอฟต์แวร์ทางการแพทย์และเคมีภัณฑ์แล้ว Werfen ยังทำธุรกิจอุปกรณ์ทางการแพทย์ผ่านทางบริษัท Leventon และบริษัทอื่น ๆ ซึ่งดูแลด้านการจัดจำหน่ายผลิตภัณฑ์
Werfen มีการดำเนินงานโดยตรงในประเทศต่าง ๆ ประมาณ 30 ประเทศ และผ่านทางตัวแทนจำหน่ายในมากกว่า 100 เขตแดน บริษัทมีพนักงานมากกว่า 5,000 คน รวมทั้งดำเนินกิจกรรมด้าน R&D และการผลิตในสหรัฐอเมริกาและยุโรป
ที่มา: Werfen
Werfen ผู้นำระดับโลกด้านการดูแลสุขภาพและชีววิทยาศาสตร์ ทำรายได้ถึง 1,337 ล้านยูโรในปี 2560 เพิ่มขึ้น 13.3% จากปี 2559
หากไม่รวมรายการที่เกิดจากการซื้อกิจการ ยอดขายจากธุรกิจเดิม (organic growth) ของบริษัทเติบโตขึ้น 4.6% ซึ่งผลประกอบการดังกล่าวนี้ทำให้ Werfen ยังคงเป็นผู้นำโลกด้านผลิตภัณฑ์ชุดตรวจวินิจฉัย (In Vitro Diagnostics) โดยบริษัทเป็นผู้จัดหาโซลูชั่นระดับนวัตกรรมให้กับโรงพยาบาลและธุรกิจห้องปฏิบัติการทางการแพทย์ ที่มีจุดมุ่งหมายเพื่อยกระดับการดูแลผู้ป่วย และลดค่าใช้จ่ายด้านการดูแลสุขภาพ
Werfen รายงานผลกำไรสุทธิ 160 ล้านยูโรในปี 2560 เพิ่มขึ้น 15.1% จากปี 2559 ขณะที่EBITDA เพิ่มขึ้น 6% แตะ 284 ล้านยูโร
Werfen มีผลการดำเนินดีมากในสาขาหลักที่บริษัทเชี่ยวชาญ เช่น Hemostasis (การห้ามเลือด) โตขึ้น 7.5% ขณะที่ Autoimmunity (ภูมิแพ้ตนเอง) ขยายตัว 6.6% ในขณะที่ไลน์ธุรกิจใหม่อย่าง Acute Care Diagnostics (การตรวจวินิจฉัยโรคเฉียบพลัน) มีอัตราการเติบโตที่ 4.8%
การขยายกลุ่มผลิตภัณฑ์เป็นหนึ่งในปัจจัยหลักที่ทำให้ยอดขายปรับตัวสูงขึ้น หลังจากที่บริษัทได้เข้าซื้อกิจการของ Tem and Accriva Diagnostics และส่งผลให้ไลน์ธุรกิจ Critical Care ได้พัฒนาไปเป็น Acute Care Diagnostics ซึ่งนำเสนอโซลูชั่นที่ครอบคลุมการดูแลในภาวะฉุกเฉิน การบาดเจ็บ และห้องผ่าตัด
Werfen ได้เสริมแกร่งธุรกิจในทุกภูมิภาคของโลก โดยเฉพาะอย่างยิ่งในจีน ที่ยอดขายพุ่งขึ้น 21% เมื่อเทียบกับปี 2559 โดยปัจจุบัน ยอดขายในภูมิภาคเอเชียแปซิฟิกคิดเป็นสัดส่วน 16% ของรายได้รวมของบริษัท
ยุโรปตะวันตกถือเป็นตลาดที่แข็งแกร่งที่สุด คิดเป็น 42% ของรายได้ทั้งหมดของ Werfen ขณะที่อเมริกาเหนือมีสัดส่วนอยู่ที่ 26% ส่วนภูมิภาคที่มีโอกาสเติบโตมากที่สุดได้แก่ ละตินอเมริกา และภูมิภาค EEMEAI (ยุโรปตะวันออก ตะวันออกกลาง แอฟริกา และอินเดีย) ซึ่งต่างทำยอดขายคิดเป็น 8% ของรายได้ทั้งหมด
สำหรับเป้าหมายที่ตั้งไว้สำหรับปี 2561 นี้ คือการสร้างความแข็งแกร่งในสาขาหลักที่บริษัทมีความเชี่ยวชาญ เดินหน้าธุรกิจในจีนให้เติบโตขึ้น และผลักดันการขยายธุรกิจในตลาดเกิดใหม่ เช่น ละตินอเมิรกา เอเชียแปซิฟิก และ EEMEAI
WERFEN เป็นหนึ่งในบริษัทชั้นนำระดับโลกด้าน IVD และดำเนินธุรกิจผ่านบริษัทในเครือ ได้แก่ Instrumentation Laboratory (Hemostasis, Acute Care Diagnostics), Inova Diagnostics (Autoimmunity) และ Biokit (OEM, การตรวจทางปฏิกริยาน้ำเหลืองเพื่อรักษาโรคติดเชื้อ) โดยนอกเหนือจากซอฟต์แวร์ทางการแพทย์และเคมีภัณฑ์แล้ว Werfen ยังทำธุรกิจอุปกรณ์ทางการแพทย์ผ่านทางบริษัท Leventon และบริษัทอื่น ๆ ซึ่งดูแลด้านการจัดจำหน่ายผลิตภัณฑ์
Werfen มีการดำเนินงานโดยตรงในประเทศต่าง ๆ ประมาณ 30 ประเทศ และผ่านทางตัวแทนจำหน่ายในมากกว่า 100 เขตแดน บริษัทมีพนักงานมากกว่า 5,000 คน รวมทั้งดำเนินกิจกรรมด้าน R&D และการผลิตในสหรัฐอเมริกาและยุโรป
ที่มา: Werfen
Werfen increases sales by over 13% and reaffirms its global leadership in in vitro diagnostics
BARCELONA, Spain--27 Apr--PRNewswire/InfoQuest
Werfen, a global leader in healthcare and life sciences, achieves revenues of 1,337 million euros in 2017, a 13.3% increase against 2016.
Excluding the impact of recent acquisitions, sales from organic growth grew by 4.6%. With these results, Werfen continues to be a global leader in in vitro diagnostics, providing innovative solutions for hospitals and commercial laboratories with the aim of improving patient care and reducing healthcare costs.
Werfen is reporting net profit of 160 million euros for 2017, representing a 15.1% increase over 2016. EBITDA has grown to 284 million euros, representing an increase of 6%.
Werfen is performing very well in its main areas of expertise. Hemostasis has an increase of 7.5%, Autoimmunity has grown by 6.6%, while the new business line, Acute Care Diagnostics, has achieved organic growth of 4.8%.
The expansion of the product portfolio has been one of the main causes of the increase in sales following the acquisitions of Tem and Accriva Diagnostics. As a result, the Critical Care business line has evolved into Acute Care Diagnostics, providing comprehensive solutions for emergency care, traumatology, and operating rooms.
Werfen has strengthened its presence in all regions, especially in China, where sales have achieved a 21% increase against 2016. Currently, Asia-Pacific accounts for 16% of total revenues.
Western Europe is the strongest market, bringing in 42% of Werfen revenues, while North America accounted for 26%. The areas with the greatest potential for growth are Latin America and EEMEAI (Eastern Europe, Middle East, Africa and India), each of which generated 8% of total sales.
The objectives set for 2018 are to further strengthen the main areas of expertise, to continue to grow in China, and to boost expansion in the emerging markets of Latin America, Asia-Pacific and EEMEAI.
WERFEN is one of the leading global corporations in IVD through its companies Instrumentation Laboratory (Hemostasis, Acute Care Diagnostics), Inova Diagnostics (Autoimmunity) and Biokit (OEM, infectious disease serology); in addition to clinical software and chemical chemistry. Werfen is also involved in medical devices through its company Leventon and other entities for distribution.
Werfen has a direct presence in around 30 countries and more than 100 territories through distributors. It has a team of over 5,000 people, and its R&D and manufacturing activities are carried out in the United States and Europe.
Werfen, a global leader in healthcare and life sciences, achieves revenues of 1,337 million euros in 2017, a 13.3% increase against 2016.
Excluding the impact of recent acquisitions, sales from organic growth grew by 4.6%. With these results, Werfen continues to be a global leader in in vitro diagnostics, providing innovative solutions for hospitals and commercial laboratories with the aim of improving patient care and reducing healthcare costs.
Werfen is reporting net profit of 160 million euros for 2017, representing a 15.1% increase over 2016. EBITDA has grown to 284 million euros, representing an increase of 6%.
Werfen is performing very well in its main areas of expertise. Hemostasis has an increase of 7.5%, Autoimmunity has grown by 6.6%, while the new business line, Acute Care Diagnostics, has achieved organic growth of 4.8%.
The expansion of the product portfolio has been one of the main causes of the increase in sales following the acquisitions of Tem and Accriva Diagnostics. As a result, the Critical Care business line has evolved into Acute Care Diagnostics, providing comprehensive solutions for emergency care, traumatology, and operating rooms.
Werfen has strengthened its presence in all regions, especially in China, where sales have achieved a 21% increase against 2016. Currently, Asia-Pacific accounts for 16% of total revenues.
Western Europe is the strongest market, bringing in 42% of Werfen revenues, while North America accounted for 26%. The areas with the greatest potential for growth are Latin America and EEMEAI (Eastern Europe, Middle East, Africa and India), each of which generated 8% of total sales.
The objectives set for 2018 are to further strengthen the main areas of expertise, to continue to grow in China, and to boost expansion in the emerging markets of Latin America, Asia-Pacific and EEMEAI.
WERFEN is one of the leading global corporations in IVD through its companies Instrumentation Laboratory (Hemostasis, Acute Care Diagnostics), Inova Diagnostics (Autoimmunity) and Biokit (OEM, infectious disease serology); in addition to clinical software and chemical chemistry. Werfen is also involved in medical devices through its company Leventon and other entities for distribution.
Werfen has a direct presence in around 30 countries and more than 100 territories through distributors. It has a team of over 5,000 people, and its R&D and manufacturing activities are carried out in the United States and Europe.
Eight Teams Advance to Langkawi Open Main Draw
32 TEAMS BATTLE IT OUT IN INTENSE QUALIFICATION MATCHES
The opening day of the Federation Internationale de Volleyball (FIVB) Beach Volleyball World Tour -- Langkawi Open 2018, organised by E-Plus Global Sdn Bhd, got underway on Thursday. The single elimination qualification games were held to determine the best four teams from each of the men and women's categories that will advance into Friday's main draw and first pool phase of the tournament.
With wins in their matches today, the four teams that will progress to the men's main draw are: Max-Jonas Karpa/Milan Sievers(Germany), Paul Becker/Eric Stadie(Germany), Simon Fruhbauer/Jorg Wutzl(Austria) and Petr Bakhnar/Taras Myskiv(Russia).
Amongst the first to progress was the German pair of Karpa/Sievers, who commented, "We did it and made it to the main draw! Hopefully we are able to play as well as we did today tomorrow and we will see how far we can go as there are a lot of good teams."
Also making it through the qualifiers Russians Bakhnar/Myskiv noted, "It's unbelievable as it was a crazy and tough game. We are so happy to make it to the main draw. We would like to thank everyone who came to support us today!"
Progressing to the women's main draw were Brittany Kendall/Stefanie Weller(Australia), Katja Stam/Julia Wouters(The Netherlands), Marta Ozolina/Agnese Caica(Latvia) and Chiyo Suzuki/Reika Murakami (Japan).
Speaking of their advancement, the Dutch pair of Stam/Wouters comments, "It is so awesome as we have worked so hard for this, all winter long. That it is working is awesome." Looking forward to the main draw matches, they added, "for us, we just want to play our own game and play what we can, I think we can surprise a few people!"
"What an awesome start to the FIVB Beach Volleyball World Tour -- Langkawi Open 2018! Well fought by all 32 teams who had to battle it out in the single elimination qualifications, demonstrating what we can expect the competition will be like over the next few days! Congratulations to the eight teams from the men's and women's categories for making it into the main draw tomorrow," comments Andrew Ching, Chief Executive Office of E-Plus Global Sdn Bhd.
Friday will see the start of the primary competition with the group phase to determine positions in the round of 12 and quarterfinals on Saturday.
The opening day of the Federation Internationale de Volleyball (FIVB) Beach Volleyball World Tour -- Langkawi Open 2018, organised by E-Plus Global Sdn Bhd, got underway on Thursday. The single elimination qualification games were held to determine the best four teams from each of the men and women's categories that will advance into Friday's main draw and first pool phase of the tournament.
With wins in their matches today, the four teams that will progress to the men's main draw are: Max-Jonas Karpa/Milan Sievers(Germany), Paul Becker/Eric Stadie(Germany), Simon Fruhbauer/Jorg Wutzl(Austria) and Petr Bakhnar/Taras Myskiv(Russia).
Amongst the first to progress was the German pair of Karpa/Sievers, who commented, "We did it and made it to the main draw! Hopefully we are able to play as well as we did today tomorrow and we will see how far we can go as there are a lot of good teams."
Also making it through the qualifiers Russians Bakhnar/Myskiv noted, "It's unbelievable as it was a crazy and tough game. We are so happy to make it to the main draw. We would like to thank everyone who came to support us today!"
Progressing to the women's main draw were Brittany Kendall/Stefanie Weller(Australia), Katja Stam/Julia Wouters(The Netherlands), Marta Ozolina/Agnese Caica(Latvia) and Chiyo Suzuki/Reika Murakami (Japan).
Speaking of their advancement, the Dutch pair of Stam/Wouters comments, "It is so awesome as we have worked so hard for this, all winter long. That it is working is awesome." Looking forward to the main draw matches, they added, "for us, we just want to play our own game and play what we can, I think we can surprise a few people!"
"What an awesome start to the FIVB Beach Volleyball World Tour -- Langkawi Open 2018! Well fought by all 32 teams who had to battle it out in the single elimination qualifications, demonstrating what we can expect the competition will be like over the next few days! Congratulations to the eight teams from the men's and women's categories for making it into the main draw tomorrow," comments Andrew Ching, Chief Executive Office of E-Plus Global Sdn Bhd.
Friday will see the start of the primary competition with the group phase to determine positions in the round of 12 and quarterfinals on Saturday.
Dali Declaration: Drive Cross-Airline Transfer Service, Building A New Type of Aviation Hub
The 6th Yunnan Aviation & Tourism Conference was held in Dali on April 26, at which representatives from 13 airport groups and OTAs of China jointly announced the Dali Declaration, advocating to grow the cross-airline transfer business, enhance the civil aviation service quality and jointly build a new type of aviation hub.
Dali Declaration
1. We, as managers of airports and OTAs, attended Dali Forum on April 26 in Dali where the building of a new type of aviation hubs in the future was discussed.
2. We recognize that the air transport industry, under the circumstance of The New Normal, still maintains steady growth with each economic indicator demonstrating a sound trend.
3. We recognize that the domestic air travel needs are robust, the throughput of airports maintains high growth, and air travel has become increasingly popular among the public.
4. We recognize that the imbalance between the demand and supply of the domestic aviation industry has become increasingly prominent, and we face a common challenge of striking a fine balance between safety and development, between safety and benefits, and between safety and normal operations.
5. We recognize that initiatives, including "Sincere Service" and "Building of Civil Aviation Service Quality System", carried out by the Civil Aviation Administration of China are aimed at driving the high quality development of the aviation industry, encouraging and promoting the application of new technologies and service innovation, and improving the public's satisfaction and sense of gain towards aviation services.
6. We recognize that under current circumstances, there is a common need and urgent desire among airports of different regions to cooperate on matters including cross-airlines transfer service and information sharing, which is an integral part of the building of a new type of aviation hub and also conducive to building groups of airports with clearly-defined functions as well as convenient national flight route network.
7. We recognize that the development level of domestic airports across different regions of China is imbalanced and these airports urgently need to strengthen their cooperation so as to continuously improve their operating efficiency and customer satisfaction.
8. We recognize that if Chinese airports set up harmonized cooperation standards, work together to improve their traveler service quality, and enhance traveler's experience, they, despite the limited resources, will be able to help more travelers access to civil aviation services, resolve the pain points in interlining among different airlines, and improve the airlines' load factor.
9. The Dali Declaration is agreed upon at this conference and the attending managers are committed to the following goals:
1 Promoting the application of new technologies, improving the standards for ground passenger and baggage service
1.1 Accelerating the building of fast customs clearance facilities at airports. Clear customs with e-boarding pass by 2019 and clear customs with documents by 2020.
1.2 Enhancing airports' capability to track baggage. Help more airlines to meet the requirements of IATA Resolution 753 in 2018 and realize the tracking of baggage status.
1.3 Improving the baggage transport efficiency of airports. Make sure the baggage transport time of connecting passengers meets the airports' MCT requirements and the baggage arrives when the passengers land at the airport.
2 Driving the formulation of cross-airlines transfer (CAT) standards
2.1 Driving the sharing of CAT data.
2.2 Supporting the through-check of baggage when a traveler makes cross-airlines transfer.
2.3 Supporting travelers who need to make a cross-airlines transfer to print their boarding pass at the previous airport.
2.4 Providing travelers who make cross-airlines transfer with assistance during the process.
2.5 Shortening the minimum connecting time (MCT) of airports.
3 Developing value-added aviation service products
All parties will, through data sharing, wok together to develop the following value-added aviation service products and set up a value-added aviation service products network:
4 Sharing and mutual access
4.1 Commit to improve the aviation service quality, promote and manage the application of new technologies and service innovation, and encourage the sharing of resources with industry counterparts.
4.2 Commit to enhance the airport's utilization efficiency and the building of regional hubs, strengthen synergy and encourage mutual access.
Dali Declaration
1. We, as managers of airports and OTAs, attended Dali Forum on April 26 in Dali where the building of a new type of aviation hubs in the future was discussed.
2. We recognize that the air transport industry, under the circumstance of The New Normal, still maintains steady growth with each economic indicator demonstrating a sound trend.
3. We recognize that the domestic air travel needs are robust, the throughput of airports maintains high growth, and air travel has become increasingly popular among the public.
4. We recognize that the imbalance between the demand and supply of the domestic aviation industry has become increasingly prominent, and we face a common challenge of striking a fine balance between safety and development, between safety and benefits, and between safety and normal operations.
5. We recognize that initiatives, including "Sincere Service" and "Building of Civil Aviation Service Quality System", carried out by the Civil Aviation Administration of China are aimed at driving the high quality development of the aviation industry, encouraging and promoting the application of new technologies and service innovation, and improving the public's satisfaction and sense of gain towards aviation services.
6. We recognize that under current circumstances, there is a common need and urgent desire among airports of different regions to cooperate on matters including cross-airlines transfer service and information sharing, which is an integral part of the building of a new type of aviation hub and also conducive to building groups of airports with clearly-defined functions as well as convenient national flight route network.
7. We recognize that the development level of domestic airports across different regions of China is imbalanced and these airports urgently need to strengthen their cooperation so as to continuously improve their operating efficiency and customer satisfaction.
8. We recognize that if Chinese airports set up harmonized cooperation standards, work together to improve their traveler service quality, and enhance traveler's experience, they, despite the limited resources, will be able to help more travelers access to civil aviation services, resolve the pain points in interlining among different airlines, and improve the airlines' load factor.
9. The Dali Declaration is agreed upon at this conference and the attending managers are committed to the following goals:
1 Promoting the application of new technologies, improving the standards for ground passenger and baggage service
1.1 Accelerating the building of fast customs clearance facilities at airports. Clear customs with e-boarding pass by 2019 and clear customs with documents by 2020.
1.2 Enhancing airports' capability to track baggage. Help more airlines to meet the requirements of IATA Resolution 753 in 2018 and realize the tracking of baggage status.
1.3 Improving the baggage transport efficiency of airports. Make sure the baggage transport time of connecting passengers meets the airports' MCT requirements and the baggage arrives when the passengers land at the airport.
2 Driving the formulation of cross-airlines transfer (CAT) standards
2.1 Driving the sharing of CAT data.
2.2 Supporting the through-check of baggage when a traveler makes cross-airlines transfer.
2.3 Supporting travelers who need to make a cross-airlines transfer to print their boarding pass at the previous airport.
2.4 Providing travelers who make cross-airlines transfer with assistance during the process.
2.5 Shortening the minimum connecting time (MCT) of airports.
3 Developing value-added aviation service products
All parties will, through data sharing, wok together to develop the following value-added aviation service products and set up a value-added aviation service products network:
4 Sharing and mutual access
4.1 Commit to improve the aviation service quality, promote and manage the application of new technologies and service innovation, and encourage the sharing of resources with industry counterparts.
4.2 Commit to enhance the airport's utilization efficiency and the building of regional hubs, strengthen synergy and encourage mutual access.
Subscribe to:
Posts (Atom)